Prosecution Insights
Last updated: October 04, 2026
Application No. 17/296,166

MICRO-NANO STRUCTURE FORMED BY SELF-ASSEMBLING ORGANIC SMALL MOLECULE COMPOUND AND USE THEREOF

Final Rejection §102§112
Filed
Dec 13, 2021
Priority
Nov 22, 2018 — CN 201811399004.6 +3 more
Examiner
DICKINSON, PAUL W
Art Unit
1618
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Qingdao University Of Science And Technology
OA Round
4 (Final)
63%
Grant Probability
Moderate
5-6
OA Rounds
0m
Est. Remaining
73%
With Interview

Examiner Intelligence

Grants 63% of resolved cases
63%
Career Allowance Rate
661 granted / 1047 resolved
+3.1% vs TC avg
Moderate +10% lift
Without
With
+9.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
39 currently pending
Career history
1086
Total Applications
across all art units

Statute-Specific Performance

§101
1.6%
-38.4% vs TC avg
§103
42.2%
+2.2% vs TC avg
§102
17.8%
-22.2% vs TC avg
§112
26.9%
-13.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1047 resolved cases

Office Action

§102 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION Applicant’s arguments, filed 7/1/2026, have been fully considered but they are not deemed to be fully persuasive. Rejections and/or objections not reiterated from previous office actions are hereby withdrawn. The following rejections and/or objects are either reiterated or newly applied. They constitute the complete set presently being applied to the instant application. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-8 and 14-16 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as failing to set forth the subject matter which the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the applicant regards as the invention. There is insufficient antecedent basis for the term “the form.” The term is not previously recited in the claim and there is therefore insufficient antecedent basis for this term. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1 and 14-15 are rejected under 35 U.S.C. 102(a)(2) as being anticipated by STN-Registry: 1045854-31-6/rn (9/22/2008) (IDS filed 9/4/2024) teaches the following compound: PNG media_image1.png 204 500 media_image1.png Greyscale Which reads on applicant’s formula I where A is a substituted heterocyclyl comprising a sulfur and nitrogen atom, L is a non-substituted conjugate carbon chain comprising four double bonds, X is O, R3 and R3 are methyl (a hydrocarbyl group), n is 0, R1, R1’ and R2 are atoms and groups with electron withdrawing ability. AS the above compound is structurally identical the present compound in claim 1, it would be fully capable of being used in the intended uses enumerated in claims 14-15. Applicant’s arguments have been fully considered but are not found persuasive. Regarding applicant’s arguments of unexpected results, applicant’s arguments are persuasive because the results, which are directed to only one or a very few examples, are not commensurate in scope with the claimed invention, which includes a myriad of compounds owing to the great breath of the claims, wherein the selections of A and the other variables in formula (I) include a myriad of compounds, and a further larger myriad of compounds as a result of the claim also including “isomers” of the structures. The few examples provided are not representative of the vast genus of compounds being claimed, nor would the artisan accept based on the limited number examples accept that the results would necessarily hold over the scope of the much broader invention claimed. Notes and Comments No prior art against the elected species was found. No prior art was found against claims 2-8 and 16. Conclusion Applicant’s amendment necessitated the new grounds of rejection in this office action. This office action is therefore made final. Any inquiry concerning this communication or earlier communications from the examiner should be directed to PAUL W DICKINSON whose telephone number is (571)270-3499. The examiner can normally be reached on M-F 9 AM to 7:30 PM. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Michael Hartley can be reached on 571-272-0616. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /PAUL W DICKINSON/Primary Examiner, Art Unit 1618 August 7, 2026
Read full office action

Prosecution Timeline

Show 2 earlier events
Jul 22, 2025
Response Filed
Oct 21, 2025
Final Rejection mailed — §102, §112
Jan 21, 2026
Response after Non-Final Action
Feb 23, 2026
Request for Continued Examination
Feb 26, 2026
Response after Non-Final Action
Apr 01, 2026
Non-Final Rejection mailed — §102, §112
Jul 01, 2026
Response Filed
Aug 11, 2026
Final Rejection mailed — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12734255
RADIOPAQUE POLYMERS WITH ENHANCED RADIOPACITY
7y 4m to grant Granted Sep 15, 2026
Patent 12734257
TERAGNOSTIC METHOD FOR CANCER PATIENTS
2y 0m to grant Granted Sep 15, 2026
Patent 12708606
LITHIUM FLUORIDE NANOPARTICLES FOR THE PROTECTION OF CHONDROCYTES IN OSTEOARTHRITIS
3y 4m to grant Granted Aug 18, 2026
Patent 12673926
NOVEL TETRAZINE COMPOUNDS FOR IN VIVO IMAGING
5y 1m to grant Granted Jul 07, 2026
Patent 12649001
COMPLEXES FOR DELIVERY OF ANTIGENIC PEPTIDES
3y 2m to grant Granted Jun 09, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
63%
Grant Probability
73%
With Interview (+9.5%)
3y 3m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 1047 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month